RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Outcomes from the CARDia Trial
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 13
SP 29
OP 29
DO 10.1177/155989771213021
UL http://mdc.sagepub.com/content/12/13/29.abstract
AB No clear evidence supports routine percutaneous coronary intervention (PCI) for patients with diabetes and multivessel disease, according to 5-year follow-up data from the Coronary Artery Revascularisation in Diabetes [CARDia; ISRCTN19872154] trial. Coronary artery bypass graft surgery is favored, unless clinical features indicate that PCI is clearly preferable.